![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Development of Bifunctional Inhibitors of Polo‐Like Kinase 1 with Low‐Nanomolar Activities Against the Polo‐Box Domain - Scharow - 2016 - ChemBioChem - Wiley Online Library
WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry - ScienceDirect
![PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33119311272773173c201b3d02ff3ad18b4a1955/2-Figure1-1.png "PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar")
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1 - RSC Chemical Biology (RSC Publishing)
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emergi | LCTT
Polo-Like Kinase 1 Inhibits the Activity of Positive Transcription Elongation Factor of RNA Pol II b (P-TEFb) | PLOS ONE
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Identification of polo‐like kinase 1 as a therapeutic target in murine lupus - Li - 2022 - Clinical & Translational Immunology - Wiley Online Library
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Polo Like Kinase-enzyme
BI_2536 - Targeting the Mitotic Kinase Polo-Like Kinase 1 (Plk1) | SpringerLink
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
